New York State Department of Health
Castle Biosciences Receives NYS DOH Approval for Skin Cancer Diagnostic
The company's DecisionDx-SCC is meant to predict risk of cutaneous squamous cell carcinoma metastasis for patients with one or more risk factors.
Applied DNA Sciences Subsidiary Gets CLIA Certification From NY State Department of Health
The company said it can now perform high-throughput SARS-CoV-2 testing with assays that have received Emergency Use Authorization from the FDA.
NY State Department of Health Approves Eurofins Viracor Transplant Rejection Tests
The Viracor TRAC donor-derived cell-free DNA test and TruGraf blood gene expression test both assess rejection status in kidney transplant recipients.
Guardant Health Receives New York State Approval for Guardant Reveal MRD Test
The assay is Guardant Health’s first commercially available product for clinical management of early-stage tumors and is initially focused on colorectal cancer.
Rady Children’s Institute for Genomic Medicine Gets NY State Approval for Sequencing Tests
The institute offers a rapid whole-genome sequencing test designed to diagnose infants and children suspected of having a rare genetic condition.